CRIS
CRIS
NASDAQ · Biotechnology

Curis Inc

$1.03
+0.12 (+13.11%)
As of Feb 8, 2:27 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.41M 3.13M 3.55M
Net Income -181,214 -134,676 -196,009
EPS
Profit Margin -5.3% -4.3% -5.5%
Rev Growth +8.9% +0.4% +3.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.36M 1.19M 1.49M
Total Equity 6.39M 5.82M 5.64M
D/E Ratio 0.21 0.21 0.27
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -236,458 -218,349 -232,431
Free Cash Flow -122,360 -122,296 -194,300